Kangstem Biotech | Investors : IR IR Letter & FAQ

본문 바로가기

KOR | ENG

주메뉴

Company
- Company
  
  Kangstem Biotech is
  engaged in various fields
  of bio-innovation.
- Company Overview
- Welcome Message
- Founder
- CEO
- Vision & Mission
- Location
Business
- Business
  
  Kangstem Biotech is
  engaged in various fields
  of bio-innovation.
- Stem Cell Therapy
- FURESTEM-OA Kit Inj.
- FURESTEM-AD® Inj.
- FURESTEM-RA® Inj.
- Advanced Regenerative Medicine
- Organoid
- Skin Organoid
- Islet Organoid
- Stem Cell and CDMO Business
- JUVENTAS
- Stem Cell Culture Business
- CDMO
- Health&Beauty Business
R & D
- R & D
  
  Kangstem Biotech is
  engaged in various fields
  of bio-innovation.
- Core Technology
- Exclusive Technology
- Umbilical Cord Blood Stem Cell
- High-Compact Technology Strategy
- Global R&D Center
- Stem Cell GMP Center
Investors
- Investors
  
  Kangstem Biotech is
  engaged in various fields
  of bio-innovation.
- Notice
- PR
- Press Release
- PR Resource Center

IR

IR Letter & FAQ

Kangstem Biotech strives to develop an innovative new drug for patients suffering from rare and incurable diseases.

Search

No Data

Company

Company Overview

Welcome Message

Founder
CEO

Vision & Mission

Business

Stem Cell Therapy

Organoid

Stem Cell and CDMO Business

Health&Beauty Business

R&D

Core Technology

Global R&D Center

Stem Cell GMP Center

Investors

Notice

IR

PR